Having trouble viewing this email? View in your browser.
ESCMID Logo

28 June 2016
WEEKLY NEWS

Dear colleagues,

Angela Huttner published a new post entitled Cheap Talkers and Dumb Mothers in the ESCMID Parity blog discussing bias women in science are still facing today.

Best regards, your ESCMID communications editors

 

Registration now open for ESCMID-ASM drug development conference

ESCMID and the American Society for Microbiology are jointly organizing a conference in Vienna from 21 – 23 September 2016 to help researchers accelerate the development of new antimicrobials for drug-resistant infections. The conference will address issues such as the reliance on very robust preclinical studies, innovative clinical trial design, strong academic/industrial partnerships, and a requirement for early engagement with regulatory bodies in order to facilitate the processes for accelerated antimicrobial development. You find more information on the conference in this press release and on the conference website. Please note that ESCMID supports “Young Scientist Members” with attendance grants for this conference. Grant application deadline is 13 July.

› Read more
 

CMI highlight: gender difference in Staphylococcus aureus bacteraemia

Researchers from Aalborg in Denmark and Seville in Spain investigated clinical outcomes in female and male patients with community-acquired Staphylococcus aureus bacteraemia (CA-SAB). They showed that female patients with CA-SAB experienced an increased 30-day mortality compared with male patients. The prognostic impact of gender was most pronounced among female patients with diabetes and cancer, while the 30-day prevalence of infective endocarditis or osteomyelitis did not differ according to gender. The researchers concluded that gender should be considered in the triage and risk stratification of CA-SAB patients. 

› Read more
 

Application still open for EU-funded PhD positions at Sepsis Academy

The European Sepsis Academy – Innovative Training Network (ESA-ITN) has 15 PhD positions available for early-stage (max. four years post-graduation) researchers wishing to focus on the pathogenesis, clinical diagnosis and monitoring of sepsis-induced immune suppression. ESA-ITN is a project supported by universities, research institutions (including ESCMID, International Sepsis Forum, European Society of Intensive Care Medicine) and companies offering an extensive sepsis-oriented joint training program to PhD students, who will benefit from attractive salary and working conditions under the European Commission’s Marie Skłodowska-Curie (MSCA) programme.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.